W
IDXX icon

WealthStone’s Idexx Laboratories IDXX Stock Holding History

WealthStone’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$257K Buy
526
+45
+9% +$22.5K 0.09% 192
2020
Q4 		$240K Buy
+481
New +$215K 0.09% 176
2019
Q3 		– Sell
-3
Closed -$825 – 308
2019
Q2 		$825 Buy
+3
New +$739 ﹤0.01% 714

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

WealthStone's IDXX Position: Q1 2021 in Review

WealthStone increased its Idexx Laboratories (IDXX) stake by 9.4% in Q1 2021, buying an estimated $22.5K and bringing the position to 526 shares worth $257K. The position accounts for 0.09% of the portfolio, ranked #192.

WealthStone first reported a position in IDXX in Q2 2019 and has held it in 3 quarters since. 1,011 funds tracked by Wall St. Rank hold IDXX as of Q1 2021.

  • WealthStone held 526 shares of Idexx Laboratories worth $257K as of Q1 2021.
  • WealthStone bought 45 Idexx Laboratories shares in Q1 2021, an estimated $22.5K.
  • Idexx Laboratories made up 0.09% of WealthStone's portfolio in Q1 2021, its #192 holding.
  • WealthStone first reported a position in Idexx Laboratories in Q2 2019 and has held it in 3 quarters since.
  • 1,011 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2021.

Based on WealthStone's 13F filing for Q1 2021, filed 13 May 2021.